田园生化主板IPO，60岁董事长李卫国“十人亲属团”参股

Core Viewpoint - Tianyuan Biochemical Co., Ltd. has received approval for its IPO on the Shenzhen Main Board, with a fundraising target of 630 million yuan for various projects, including a regional R&D center and new sales channel development [3][5]. Company Overview - Tianyuan Biochemical was established in 2001, with a registered capital of 105 million yuan, located in Nanning, Guangxi Zhuang Autonomous Region. The company focuses on the R&D, production, and sales of pesticide formulations [3]. Financial Performance - The company's projected financials for 2022 to 2024 show revenues of 1.712 billion yuan, 1.774 billion yuan, and 1.750 billion yuan, respectively. Net profits are expected to be 162 million yuan, 229 million yuan, and 249 million yuan for the same years [9]. Shareholding Structure - The actual controller of Tianyuan Biochemical is Li Weiguo, who holds 45.08% of the voting rights. He is also the chairman and general manager of the company [5][6]. - The top ten individual shareholders collectively hold 35.99% of the shares, with Li Weiguo directly holding 5.47% and indirectly holding an additional 10.01% [6][7]. Investment Projects - The company plans to use the raised funds for several projects, including the construction of a regional R&D center and the development of new sales channels for agricultural services [5][8].